- Home
- GRRR vs LSTA Comparison
GRRR vs LSTA Comparison
Compare GRRR & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- LSTA
- Stock Information
- Founded
- GRRR 2001
- LSTA 1980
- Country
- GRRR United Kingdom
- LSTA United States
- Employees
- GRRR N/A
- LSTA N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- LSTA Misc Health and Biotechnology Services
- Sector
- GRRR Technology
- LSTA Health Care
- Exchange
- GRRR Nasdaq
- LSTA Nasdaq
- Market Cap
- GRRR 28.7M
- LSTA 24.2M
- IPO Year
- GRRR N/A
- LSTA N/A
- Fundamental
- Price
- GRRR $4.32
- LSTA $2.77
- Analyst Decision
- GRRR Buy
- LSTA Strong Buy
- Analyst Count
- GRRR 1
- LSTA 1
- Target Price
- GRRR $9.00
- LSTA $15.00
- AVG Volume (30 Days)
- GRRR 586.8K
- LSTA 14.6K
- Earning Date
- GRRR 11-22-2024
- LSTA 11-12-2024
- Dividend Yield
- GRRR N/A
- LSTA N/A
- EPS Growth
- GRRR N/A
- LSTA N/A
- EPS
- GRRR 2.28
- LSTA N/A
- Revenue
- GRRR $78,940,347.00
- LSTA N/A
- Revenue This Year
- GRRR $15.59
- LSTA N/A
- Revenue Next Year
- GRRR $20.59
- LSTA N/A
- P/E Ratio
- GRRR $1.89
- LSTA N/A
- Revenue Growth
- GRRR 424.97
- LSTA N/A
- 52 Week Low
- GRRR $2.09
- LSTA $2.05
- 52 Week High
- GRRR $13.00
- LSTA $3.83
- Technical
- Relative Strength Index (RSI)
- GRRR 53.71
- LSTA 39.99
- Support Level
- GRRR $4.16
- LSTA $2.75
- Resistance Level
- GRRR $4.76
- LSTA $2.94
- Average True Range (ATR)
- GRRR 0.32
- LSTA 0.21
- MACD
- GRRR -0.02
- LSTA -0.01
- Stochastic Oscillator
- GRRR 48.75
- LSTA 7.81
About GRRR Gorilla Technology Group Inc. Ordinary shares
Gorilla Technology Group Inc is primarily engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.